CHP
FLXN

Castle Hook Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Castle Hook Partners’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-73,316
Closed -$1.77M – 86
2017
Q3 		$1.77M Buy
+73,316
New +$1.72M 0.06% 51

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Castle Hook Partners's FLXN Position: Q4 2017 in Review

Castle Hook Partners sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2017, closing a stake of 73,316 shares — an estimated $1.77M sold.

Castle Hook Partners first reported a position in FLXN in Q3 2017 and held it in 1 quarter. The position peaked at $1.77M in Q3 2017. 139 funds tracked by Wall St. Rank hold FLXN as of Q4 2017.

  • Castle Hook Partners reported no remaining Flexion Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Castle Hook Partners sold 73,316 Flexion Therapeutics, Inc. shares in Q4 2017, an estimated $1.77M.
  • Castle Hook Partners first reported a position in Flexion Therapeutics, Inc. in Q3 2017 and held it in 1 quarter.
  • Castle Hook Partners's Flexion Therapeutics, Inc. position peaked at $1.77M in Q3 2017.
  • 139 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2017.

Based on Castle Hook Partners's 13F filing for Q4 2017, filed 14 Feb 2018.